ASHPOfficial

In this Pharmacy Leadership Episode, Christi Jen, sits down with the Section of Clinical Specialists and Scientists Awardee Rena Gosser to discuss what membership within the Section and ASHP means to him and how it has helped him develop as a pharmacy practice leader. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Learn from experts in the field on the current status and future of COVID-19. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join a discussion between two trailblazing pharmacy practice researchers on the value of pharmacist researchers, how a PharmD graduate can start doing research, and how to maintain it over a career. Kevin Garey, the 2023 recipient of the ASHP Foundation Award for Sustained Contributions will be sharing his secrets of success with C. Michael White, a past awardee and chair of the ASHP Foundation Research Advisory Council. Whether you are just starting out or are mid-career in research, this podcast is for you! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast delves into effective strategies tailored for new practitioners stepping into leadership positions, like residency program leadership or clinical coordination, where they must manage and teach individuals with greater experience. It emphasizes the delicate balance of integrating fresh ideas while respecting existing practices, recognizing that learning is a continuous journey for everyone involved. The discussion underscores the importance of remaining open to new ideas from team members and embracing a mindset of acknowledging one's limitations to navigate potential challenges successfully. Drawing from the insights of experienced leaders from the SCSS Clinical Leadership SAG, listeners gain practical advice and valuable insights into thriving in such leadership roles. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast, hosted by the Pharmacy Administration and Leadership Residents’ Collaborative (PALRC), is intended to give new and upcoming pharmacy leaders and managers tips for navigating upcoming job interviews post-residency. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Learn from experts on compliance with USP Chapter <797> in small and rural hospitals. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In November 2021, Arkansas enacted a law, known as Act 1103, that prohibited drugmakers from placing restrictions on 340B contract pharmacies and child sites. The Pharmaceutical Research and Manufacturers of America (PhRMA) immediately filed suit to block implementation of Act 1103, delaying enforcement of the law for nearly 2 years. However, on March 12, 2024, the U.S. Court of Appeals for the Eighth Circuit rejected PhRMA’s arguments and ruled Act 1103 is valid and enforceable. In the podcast, we talk about the implications of the ruling for the broader 340B program and covered entities nationwide. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, members of the Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) discuss strategies and advice to help future residents navigate the post-match process. Speakers highlight important steps that newly-matched residents can take to set themselves up for a successful transition into their residency positions. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Recent trends indicate the GLP-1 market will exceed $100 billion by 2030; this is not a surprise for the health care system as discussion and use of these medications within this class has continued to soar. As the prescribing of these medications continue to increase, pharmacists in all settings must be well versed to ensure they are able to provide appropriate counseling, education, and adjustments for patients and provide clinical insight to the healthcare team. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, we will be discussing development and implementation of a collaborative practice agreement within an integrated health system specialty pharmacy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Pharmacy Leadership episode, Sarah Stephens sits down with the Section of Inpatient Care Practitioners 2023 Distinguished Service Awardee, Lois Parker, to discuss what membership within the section and ASHP means to her and how it helped her develop as a pharmacy practice leader during her career. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Respiratory syncytial virus is a viral illness that usually causes mild, cold-like symptoms. RSV vaccine can help prevent lower respiratory tract disease caused by RSV. This podcast will discuss the use of the RSV vaccine in adults and pregnancy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join the ASHP Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) for a candid conversation among pharmacy administration and leadership residents as they discuss how meaningful connections can propel you towards your next professional milestones and reshape your approach to success. Let the shared experiences and invaluable guidance of our guests inspire next steps in your career journey in this captivating exploration of what lies ahead in the world of possibilities. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

4 recipients of the 2023 ASHP Foundation Literature Awardees discuss their projects and approaches to pharmacy research. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The National Institute for Occupational Safety and Health (NIOSH) is the federal research institute focused on the study of worker safety and health and empowering employers and workers to create safe and healthy workplaces, and the Dr. Lorna Breen Heroes’ Foundation is the only nonprofit organization exclusively focused on healthcare worker mental health and well-being. NIOSH and the Dr. Lorna Breen Heroes’ Foundation recently released the Impact Wellbeing Guide, which provides hospital leadership with step-by-step guidance to make operational changes that improve healthcare worker wellbeing within their hospitals. In this podcast, we will discuss the Guide and its resources, as well as how hospital leaders can use it to build a system where pharmacists – and all healthcare workers – thrive. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Lindsay Bowman, Dr. Olivia Berger, and Dr. Suzanne Nesbit discuss the AJHP Descriptive Report, “Operationalizing the new DEA exception: A novel process for dispensing of methadone for opioid use disorder at discharge from acute care settings,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Pharmacy Leadership Episode, Justin Moore, Chair of the New Practitioners Forum (NPF) Executive Committee, sits down with the 2023 NPF Distinguished Service Awardee, Joe Marchiano, to discuss what membership within the Forum and ASHP means to him and how it has helped him develop as a pharmacy practice leader. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Learn from experts in the field on optimizing PARP inhibitor outcomes in cancer therapy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast provides an engaging interview with three pharmacy leaders who have had successful careers and contributed to health system professional associations. Lindsey Kelley, Christy Norman, and Suzanne Shea will share their insights on their professional journeys as pharmacists and executive leaders and what it means to lead with authenticity. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join experts as they discuss similarities and differences between improvement and implementation science and how to incorporate rigor in projects to expand dissemination opportunities and practice change. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.